Accuray Q4 Revenue Plunges 21%, FY26 Loss Widens to $49M
ARAY sits 36% above its 52-week low of $0.22.
Summary
Accuray's Q4 revenue fell 21% to $100.9M, with product revenue down 42% to $40.8M, while service revenue grew 6% to $60.1M. Full-year revenue dropped 12% to $401.9M and the net loss widened to $49.2M from $1.6M. Gross orders collapsed 33% to $191.9M and backlog shrank 27% to $312.5M. The company withheld FY27 guidance, citing geopolitical and tariff uncertainty, but expects continued growth in service revenue. This follows the $55M recapitalization announced July 29 and the pending reverse stock split vote. The transformation plan exceeded its cost-savings target, but demand deterioration is severe and the balance sheet remains strained with $146M in long-term debt against $41M in cash.
At the time of this announcement, ARAY was trading at $0.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $35.2M. The 52-week trading range was $0.22 to $2.10. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.